Logo image of ELI.BR

ELIA GROUP SA/NV (ELI.BR) Stock Fundamental Analysis

EBR:ELI - Euronext Brussels - BE0003822393 - Common Stock - Currency: EUR

90.15  +2.7 (+3.09%)

Fundamental Rating

2

Taking everything into account, ELI scores 2 out of 10 in our fundamental rating. ELI was compared to 17 industry peers in the Electric Utilities industry. ELI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ELI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ELI had positive earnings in the past year.
ELI had a negative operating cash flow in the past year.
Each year in the past 5 years ELI has been profitable.
The reported operating cash flow has been mixed in the past 5 years: ELI reported negative operating cash flow in multiple years.
ELI.BR Yearly Net Income VS EBIT VS OCF VS FCFELI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B

1.2 Ratios

With a Return On Assets value of 1.54%, ELI is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
ELI's Return On Equity of 6.57% is on the low side compared to the rest of the industry. ELI is outperformed by 82.35% of its industry peers.
The Return On Invested Capital of ELI (2.74%) is worse than 82.35% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ELI is significantly below the industry average of 9.46%.
Industry RankSector Rank
ROA 1.54%
ROE 6.57%
ROIC 2.74%
ROA(3y)1.62%
ROA(5y)1.67%
ROE(3y)6.29%
ROE(5y)6.24%
ROIC(3y)2.92%
ROIC(5y)3.23%
ELI.BR Yearly ROA, ROE, ROICELI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8

1.3 Margins

With a decent Profit Margin value of 9.72%, ELI is doing good in the industry, outperforming 70.59% of the companies in the same industry.
In the last couple of years the Profit Margin of ELI has declined.
ELI has a Operating Margin (19.30%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ELI has declined.
ELI has a Gross Margin (43.75%) which is in line with its industry peers.
ELI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 19.3%
PM (TTM) 9.72%
GM 43.75%
OM growth 3Y-12.99%
OM growth 5Y-5.8%
PM growth 3Y-9.3%
PM growth 5Y-9.9%
GM growth 3Y-5.05%
GM growth 5Y-3.05%
ELI.BR Yearly Profit, Operating, Gross MarginsELI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

0

2. Health

2.1 Basic Checks

ELI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ELI has about the same amount of shares outstanding.
Compared to 5 years ago, ELI has more shares outstanding
The debt/assets ratio for ELI is higher compared to a year ago.
ELI.BR Yearly Shares OutstandingELI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ELI.BR Yearly Total Debt VS Total AssetsELI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.71, we must say that ELI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.71, ELI is doing worse than 82.35% of the companies in the same industry.
ELI has a Debt/Equity ratio of 2.22. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.22, ELI is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.22
Debt/FCF N/A
Altman-Z 0.71
ROIC/WACC0.59
WACC4.68%
ELI.BR Yearly LT Debt VS Equity VS FCFELI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B 6B 8B

2.3 Liquidity

ELI has a Current Ratio of 0.87. This is a bad value and indicates that ELI is not financially healthy enough and could expect problems in meeting its short term obligations.
ELI has a Current ratio of 0.87. This is in the lower half of the industry: ELI underperforms 70.59% of its industry peers.
A Quick Ratio of 0.85 indicates that ELI may have some problems paying its short term obligations.
With a Quick ratio value of 0.85, ELI perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.85
ELI.BR Yearly Current Assets VS Current LiabilitesELI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

5

3. Growth

3.1 Past

The earnings per share for ELI have decreased by -0.88% in the last year.
Measured over the past years, ELI shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.12% on average per year.
The Revenue for ELI has decreased by -13.66% in the past year. This is quite bad
Measured over the past years, ELI shows a quite strong growth in Revenue. The Revenue has been growing by 14.71% on average per year.
EPS 1Y (TTM)-0.88%
EPS 3Y6.78%
EPS 5Y-0.12%
EPS Q2Q%5.88%
Revenue 1Y (TTM)-13.66%
Revenue growth 3Y20.26%
Revenue growth 5Y14.71%
Sales Q2Q%1.32%

3.2 Future

ELI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.71% yearly.
Based on estimates for the next years, ELI will show a quite strong growth in Revenue. The Revenue will grow by 11.43% on average per year.
EPS Next Y13.81%
EPS Next 2Y8.32%
EPS Next 3Y9.69%
EPS Next 5Y9.71%
Revenue Next Year0.81%
Revenue Next 2Y9.64%
Revenue Next 3Y12.55%
Revenue Next 5Y11.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ELI.BR Yearly Revenue VS EstimatesELI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
ELI.BR Yearly EPS VS EstimatesELI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.26, the valuation of ELI can be described as rather expensive.
70.59% of the companies in the same industry are cheaper than ELI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.92, ELI is valued a bit cheaper.
A Price/Forward Earnings ratio of 17.77 indicates a rather expensive valuation of ELI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELI is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ELI to the average of the S&P500 Index (21.65), we can say ELI is valued inline with the index average.
Industry RankSector Rank
PE 19.26
Fwd PE 17.77
ELI.BR Price Earnings VS Forward Price EarningsELI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

64.71% of the companies in the same industry are cheaper than ELI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.55
ELI.BR Per share dataELI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

ELI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.39
PEG (5Y)N/A
EPS Next 2Y8.32%
EPS Next 3Y9.69%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.61%, ELI has a reasonable but not impressive dividend return.
ELI's Dividend Yield is slightly below the industry average, which is at 4.51.
Compared to the average S&P500 Dividend Yield of 2.51, ELI is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

The dividend of ELI has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years5
Div Non Decr Years5
ELI.BR Yearly Dividends per shareELI.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

ELI pays out 42.58% of its income as dividend. This is a bit on the high side, but may be sustainable.
ELI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP42.58%
EPS Next 2Y8.32%
EPS Next 3Y9.69%
ELI.BR Yearly Income VS Free CF VS DividendELI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B
ELI.BR Dividend Payout.ELI.BR Dividend Payout, showing the Payout Ratio.ELI.BR Dividend Payout.PayoutRetained Earnings

ELIA GROUP SA/NV

EBR:ELI (4/24/2025, 7:00:00 PM)

90.15

+2.7 (+3.09%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)03-07 2025-03-07/bmo
Earnings (Next)05-21 2025-05-21
Inst Owners16.33%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap9.83B
Analysts78.46
Price Target98.62 (9.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly Dividend1.91
Dividend Growth(5Y)3.71%
DP42.58%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.97%
PT rev (3m)-19.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.27%
EPS NY rev (3m)-3.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 19.26
Fwd PE 17.77
P/S 2.78
P/FCF N/A
P/OCF N/A
P/B 1.88
P/tB 4.01
EV/EBITDA 15.55
EPS(TTM)4.68
EY5.19%
EPS(NY)5.07
Fwd EY5.63%
FCF(TTM)-37.38
FCFYN/A
OCF(TTM)-6.86
OCFYN/A
SpS32.4
BVpS47.98
TBVpS22.49
PEG (NY)1.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.54%
ROE 6.57%
ROCE 3.77%
ROIC 2.74%
ROICexc 3.17%
ROICexgc 3.85%
OM 19.3%
PM (TTM) 9.72%
GM 43.75%
FCFM N/A
ROA(3y)1.62%
ROA(5y)1.67%
ROE(3y)6.29%
ROE(5y)6.24%
ROIC(3y)2.92%
ROIC(5y)3.23%
ROICexc(3y)3.76%
ROICexc(5y)3.9%
ROICexgc(3y)4.95%
ROICexgc(5y)5.19%
ROCE(3y)4.02%
ROCE(5y)4.44%
ROICexcg growth 3Y-2.67%
ROICexcg growth 5Y-10.8%
ROICexc growth 3Y-1.76%
ROICexc growth 5Y-6.46%
OM growth 3Y-12.99%
OM growth 5Y-5.8%
PM growth 3Y-9.3%
PM growth 5Y-9.9%
GM growth 3Y-5.05%
GM growth 5Y-3.05%
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 2.22
Debt/FCF N/A
Debt/EBITDA 9.2
Cap/Depr 573.52%
Cap/Sales 94.19%
Interest Coverage 2.73
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.85
Altman-Z 0.71
F-Score3
WACC4.68%
ROIC/WACC0.59
Cap/Depr(3y)327.32%
Cap/Depr(5y)309.75%
Cap/Sales(3y)50.5%
Cap/Sales(5y)50.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.88%
EPS 3Y6.78%
EPS 5Y-0.12%
EPS Q2Q%5.88%
EPS Next Y13.81%
EPS Next 2Y8.32%
EPS Next 3Y9.69%
EPS Next 5Y9.71%
Revenue 1Y (TTM)-13.66%
Revenue growth 3Y20.26%
Revenue growth 5Y14.71%
Sales Q2Q%1.32%
Revenue Next Year0.81%
Revenue Next 2Y9.64%
Revenue Next 3Y12.55%
Revenue Next 5Y11.43%
EBIT growth 1Y11.95%
EBIT growth 3Y4.64%
EBIT growth 5Y8.05%
EBIT Next Year115.09%
EBIT Next 3Y50.52%
EBIT Next 5Y35.26%
FCF growth 1Y-328.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-123.39%
OCF growth 3YN/A
OCF growth 5YN/A